Agilon Health (NYSE:AGL) Shares Down 5.1% – What’s Next?

Agilon Health, Inc. (NYSE:AGL)’s stock price fell 5.1% during mid-day trading on Tuesday . The stock traded as low as $81.95 and last traded at $81.97. 107,183 shares were traded during mid-day trading, a decline of 71% from the average session volume of 365,729 shares. The stock had previously closed at $86.39.

Wall Street Analyst Weigh In

Several brokerages have issued reports on AGL. Weiss Ratings raised Agilon Health from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, May 12th. Jefferies Financial Group raised Agilon Health from a “hold” rating to a “buy” rating and raised their target price for the stock from $27.50 to $48.00 in a research report on Thursday, May 7th. Benchmark reissued a “buy” rating and issued a $95.00 target price (up from $13.00) on shares of Agilon Health in a research report on Thursday, May 21st. Wells Fargo & Company reissued an “overweight” rating and issued a $72.00 target price (up from $37.50) on shares of Agilon Health in a research report on Friday, May 8th. Finally, Barclays raised Agilon Health from an “underweight” rating to an “equal weight” rating and set a $81.00 target price on the stock in a research report on Tuesday. Five equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $58.73.

Agilon Health Trading Down 2.2%

The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.04 and a current ratio of 1.04. The stock has a market capitalization of $1.41 billion, a PE ratio of -3.92 and a beta of 2.29. The stock has a 50-day moving average price of $33.62 and a two-hundred day moving average price of $22.87.

Agilon Health (NYSE:AGL) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.04 by $0.76. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.The firm had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.38 billion. As a group, equities analysts forecast that Agilon Health, Inc. will post -3.75 earnings per share for the current year.

Institutional Trading of Agilon Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Alpine Global Management LLC bought a new stake in Agilon Health during the 4th quarter valued at approximately $84,000. Invesco Ltd. increased its stake in Agilon Health by 30.7% in the 4th quarter. Invesco Ltd. now owns 1,004,266 shares of the company’s stock worth $692,000 after acquiring an additional 235,951 shares during the last quarter. Mercer Global Advisors Inc. ADV bought a new stake in Agilon Health in the 4th quarter worth approximately $86,000. Numerai GP LLC increased its stake in Agilon Health by 207.3% in the 4th quarter. Numerai GP LLC now owns 1,228,071 shares of the company’s stock worth $846,000 after acquiring an additional 828,472 shares during the last quarter. Finally, Odyssean LLC bought a new stake in Agilon Health in the 4th quarter worth approximately $96,000.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.